Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

PHASE3CompletedINTERVENTIONAL
Enrollment

455

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

May 31, 2010

Study Completion Date

July 31, 2012

Conditions
Sarcoma
Interventions
BIOLOGICAL

pegfilgrastim

DRUG

doxorubicin hydrochloride

DRUG

ifosfamide

PROCEDURE

multimodality therapy

Trial Locations (41)

1000

Institut Jules Bordet, Brussels

13385

CHU de la Timone, Marseille

28040

Hospital Universitario San Carlos, Madrid

33076

Institut Bergonie, Bordeaux

69373

Centre Leon Berard, Lyon

A-8010

Karl-Franzens-University Graz, Graz

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

B-3000

U.Z. Gasthuisberg, Leuven

T2N 4N2

Tom Baker Cancer Centre - Calgary, Calgary

T6G 1Z2

Cross Cancer Institute at University of Alberta, Edmonton

A1B 3V6

Doctor H. Bliss Murphy Cancer Centre, St. John's

L8V 5C2

Margaret and Charles Juravinski Cancer Centre, Hamilton

H3G 1Y6

McGill Cancer Centre at McGill University, Montreal

DK-8000

Aarhus Universitetshospital - Aarhus Sygehus, Aarhus

DK-2730

Copenhagen County Herlev University Hospital, Copenhagen

D-50924

Medizinische Universitaetsklinik I at the University of Cologne, Cologne

D-01307

Universitatsklinikum Carl Gustav Carus, Dresden

D-45122

Universitaetsklinikum Essen, Essen

D-30625

Medizinische Hochschule Hannover, Hanover

D-68135

Klinikum der Stadt Mannheim, Mannheim

D-81377

Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich

D-72076

Southwest German Cancer Center at Eberhard-Karls-University, Tübingen

1066 CX

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam

9700 RB

University Medical Center Groningen, Groningen

2300 CA

Leiden University Medical Center, Leiden

NL-6500 HB

Universitair Medisch Centrum St. Radboud - Nijmegen, Nijmegen

3000 CA

University Medical Center Rotterdam at Erasmus Medical Center, Rotterdam

833 10

National Cancer Institute - Bratislava, Bratislava

08035

Vall d'Hebron University Hospital, Barcelona

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

B15 2TH

Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

SW3 6JJ

Royal Marsden - London, London

WIT 3AA

University College of London Hospitals, London

NE4 6BE

Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle upon Tyne

PL6 8DH

Derriford Hospital, Plymouth

S1O 2SJ

Cancer Research Centre at Weston Park Hospital, Sheffield

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

EH4 2XU

Edinburgh Cancer Centre at Western General Hospital, Edinburgh

G11 6NT

Western Infirmary, Glasgow

G12 0YN

Gartnavel General Hospital, Glasgow

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00061984 - Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter